Advocates should focus on long-term strategy to fight HIV/AIDS

HIV/AIDS advocates should focus on developing a long-term strategy for the fight against the pandemic, Global Fund To Fight AIDS, Tuberculosis and Malaria Executive Director Richard Feachem said on Wednesday during a satellite meeting at the World Economic Forum in Davos, Switzerland, Reuters Health reports.

"As we get the fire engine to the scene and begin to put out the blaze, which I think is what is happening, our attention now must begin to focus on the long term," Feachem said.

He added that during the past five years, countries have become more proactive in their approaches to tackling HIV/AIDS and, as a result, have accomplished "some early successes."

According to Feachem, 1.5 million people worldwide have access to antiretroviral therapy, and the number is "doubling every year."

However, for every one person with access to treatment, 10 new HIV transmissions occur, Feachem said, adding that the result is a "receding horizon" that the world needs to address.

In addition, rising costs associated with expanded drug treatment programs pose a serious challenge as HIV-positive people remain on therapy longer and likely require more expensive second- and third-line drugs because of drug resistance, according to Reuters Health.

"Unless we really focus on those long-term issues and get a high measure of agreement, we are not going to make the right decisions today and tomorrow," Feachem said.

He also noted that decisions would have to be made in the near future about the role of vaginal microbicides -- gels, films and sponges that could help prevent the sexual transmission of HIV and other infections -- male circumcision and vaccines in the fight against HIV/AIDS worldwide (Hirschler, Reuters Health, 1/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exclusion of indigenous voices hinders HIV progress in Latin America